- Markets
- Healthcare
- KERALAYUR
KERALAYUR
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Kerala Ayurveda To Consider Issuance Of Shares Via Preferential Allotment
Dec 4 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA - TO CONSIDER ISSUANCE OF SHARES VIA PREFERENTIAL ALLOTMENT
KERALA AYURVEDA - PROPOSAL FOR FUND RAISING BY WAY OF PREFERENTIAL ALLOTMENT
Further company coverage: KEAY.BO
(([email protected];))
Dec 4 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA - TO CONSIDER ISSUANCE OF SHARES VIA PREFERENTIAL ALLOTMENT
KERALA AYURVEDA - PROPOSAL FOR FUND RAISING BY WAY OF PREFERENTIAL ALLOTMENT
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda Approved Issue Of Shares Worth Upto 218.3 Mln Rupees
Nov 24 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED ISSUE OF SHARES WORTH UPTO 218.3 MILLION RUPEES
Source text for Eikon: ID:nBSE313GG0
Further company coverage: KEAY.BO
(([email protected];))
Nov 24 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED ISSUE OF SHARES WORTH UPTO 218.3 MILLION RUPEES
Source text for Eikon: ID:nBSE313GG0
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda To Consider Fund Raising
Nov 21 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSESVLhD
Further company coverage: KEAY.BO
(([email protected];))
Nov 21 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
TO CONSIDER FUND RAISING
Source text for Eikon: ID:nBSESVLhD
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda Names Vivek Sunder CEO
Oct 3 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
NAMES VIVEK SUNDER CEO
Further company coverage: KEAY.BO
(([email protected];))
Oct 3 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
NAMES VIVEK SUNDER CEO
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda Approves Preferential Issue Of Shares Up To 69.5 Million Rupees
Aug 31 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED PREFERENTIAL ISSUE OF SHARES UP TO 69.5 MILLION RUPEES
APPROVED SALE/TRANSFER OF LAND IN BANGALORE
APPROVED SALE/TRANSFER OF LAND TOWARDS USE OF SALE PROCEEDS TO SETTLE PARTIALLY LOAN EXTENDED BY KATRA HOLDINGS
SALE CONSIDERATION OF LAND AT 81.4 MILLION RUPEES
Source text for Eikon: ID:nBSE8GYd4Q
Further company coverage: KEAY.BO
(([email protected];))
Aug 31 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED PREFERENTIAL ISSUE OF SHARES UP TO 69.5 MILLION RUPEES
APPROVED SALE/TRANSFER OF LAND IN BANGALORE
APPROVED SALE/TRANSFER OF LAND TOWARDS USE OF SALE PROCEEDS TO SETTLE PARTIALLY LOAN EXTENDED BY KATRA HOLDINGS
SALE CONSIDERATION OF LAND AT 81.4 MILLION RUPEES
Source text for Eikon: ID:nBSE8GYd4Q
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda To Consider Issuance Of Shares Via Preferential Allotment
Aug 28 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
TO CONSIDER ISSUANCE OF SHARES VIA PREFERENTIAL ALLOTMENT
Source text for Eikon: ID:nBSE2NtsTp
Further company coverage: KEAY.BO
(([email protected];))
Aug 28 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
TO CONSIDER ISSUANCE OF SHARES VIA PREFERENTIAL ALLOTMENT
Source text for Eikon: ID:nBSE2NtsTp
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda To Enter Into Business Transfer Agreement For Purchase Of Nutraceutical Product Range- Nutraveda
July 12 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED ENTERING INTO A BUSINESS TRANSFER AGREEMENT FOR PURCHASE OF NUTRACEUTICAL PRODUCT RANGE- NUTRAVEDA
CO WILL NOT BE CHARGED ANY CONSIDERATION FOR DEAL
10% MARK UP ON COST WILL BE CHARGED ON THE PRODUCT SUPPLY TO CO BY KATRA PHYTOCHEM INDIA
Source text for Eikon: ID:nBSEYMjbl
Further company coverage: KEAY.BO
(([email protected];))
July 12 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
APPROVED ENTERING INTO A BUSINESS TRANSFER AGREEMENT FOR PURCHASE OF NUTRACEUTICAL PRODUCT RANGE- NUTRAVEDA
CO WILL NOT BE CHARGED ANY CONSIDERATION FOR DEAL
10% MARK UP ON COST WILL BE CHARGED ON THE PRODUCT SUPPLY TO CO BY KATRA PHYTOCHEM INDIA
Source text for Eikon: ID:nBSEYMjbl
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda To Issue Shares Worth 72.8 Million Rupees
May 11 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA LTD - TO ISSUE SHARES WORTH 72.8 MILLION RUPEES
KERALA AYURVEDA LTD - TO ISSUE SHARES FOR CASH AT A PRICE OF 104 RUPEES PER SHARE ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE9XbcZ0
Further company coverage: KEAY.BO
(([email protected];))
May 11 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA LTD - TO ISSUE SHARES WORTH 72.8 MILLION RUPEES
KERALA AYURVEDA LTD - TO ISSUE SHARES FOR CASH AT A PRICE OF 104 RUPEES PER SHARE ON PREFERENTIAL BASIS
Source text for Eikon: ID:nBSE9XbcZ0
Further company coverage: KEAY.BO
(([email protected];))
Kerala Ayurveda To Consider Issuance Of Shares Via Preferential Allotment
May 8 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA LTD - TO CONSIDER ISSUANCE OF EQUITY SHARES BY WAY OF A PREFERENTIAL ALLOTMENT TO INVESTORS
Source text for Eikon: ID:nBSE67K6nS
Further company coverage: KEAY.BO
(([email protected];))
May 8 (Reuters) - Kerala Ayurveda Ltd KEAY.BO:
KERALA AYURVEDA LTD - TO CONSIDER ISSUANCE OF EQUITY SHARES BY WAY OF A PREFERENTIAL ALLOTMENT TO INVESTORS
Source text for Eikon: ID:nBSE67K6nS
Further company coverage: KEAY.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Kerala Ayurveda do?
Founded in 1945 by Late Vaidyan K G K Panicker, KAL is a leading Ayurvedic company in Kerala, India. It blends tradition with modern technology and qualified staff.
Who are the competitors of Kerala Ayurveda?
Kerala Ayurveda major competitors are Lyka Labs, Brooks Laboratories, Aayush Wellness, Zenotech Laboratorie, Valiant Laboratories, Zim Laboratories, Kappac Pharma. Market Cap of Kerala Ayurveda is ₹391 Crs. While the median market cap of its peers are ₹399 Crs.
Is Kerala Ayurveda financially stable compared to its competitors?
Kerala Ayurveda seems to be less financially stable compared to its competitors. Altman Z score of Kerala Ayurveda is 3.43 and is ranked 6 out of its 8 competitors.
Does Kerala Ayurveda pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Kerala Ayurveda latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Kerala Ayurveda allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Kerala Ayurveda balance sheet?
Balance sheet of Kerala Ayurveda is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Kerala Ayurveda improving?
The profit is oscillating. The profit of Kerala Ayurveda is ₹1.51 Crs for TTM, -₹1.56 Crs for Mar 2024 and -₹0.53 Crs for Mar 2023.
Is the debt of Kerala Ayurveda increasing or decreasing?
Yes, The debt of Kerala Ayurveda is increasing. Latest debt of Kerala Ayurveda is ₹56.21 Crs as of Sep-24. This is greater than Mar-24 when it was ₹24.07 Crs.
Is Kerala Ayurveda stock expensive?
Kerala Ayurveda is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Kerala Ayurveda is 574, while 3 year average PE is 38.92. Also latest EV/EBITDA of Kerala Ayurveda is 54.44 while 3yr average is 61.89.
Has the share price of Kerala Ayurveda grown faster than its competition?
Kerala Ayurveda has given better returns compared to its competitors. Kerala Ayurveda has grown at ~8.21% over the last 1yrs while peers have grown at a median rate of -3.29%
Is the promoter bullish about Kerala Ayurveda?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Kerala Ayurveda is 58.58% and last quarter promoter holding is 58.58%.
Are mutual funds buying/selling Kerala Ayurveda?
The mutual fund holding of Kerala Ayurveda is stable. The current mutual fund holding in Kerala Ayurveda is 0.02% while previous quarter holding is 0.02%.